Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20404 | 1.00 | HTR1A (0.55) | HTR1AKDM1AMAOB | |
| SCHEMBL26634553 | 0.91 | HTR1A (0.62) | HTR1AMAOB | |
| SCHEMBL6970401 | 0.90 | HTR1A (0.64) | HTR1AKDM1AMAOB | |
| SCHEMBL829254 | 0.90 | HTR1A (0.64) | HTR1AMAOB | |
| SCHEMBL6964152 | 0.90 | HTR1A (0.64) | HTR1AKDM1AMAOB | |
| SCHEMBL7083797 | 0.89 | HTR1A (0.65) | HTR1AMAOB | |
| Hydrochloric Acid SCHEMBL829918 | 0.89 | HTR1A (0.62) | HTR1AMAOB | |
| Hydrochloric Acid SCHEMBL2558698 | 0.89 | HTR1A (0.62) | HTR1AMAOB | |
| Hydrochloric Acid SCHEMBL2557258 | 0.87 | HTR1A (0.63) | HTR1AMAOB | |
| SCHEMBL23164620 | 0.87 | HTR1A (0.67) | HTR1AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | claimed |
| EP-4514595-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | claimed |
| EP-4240578-B1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC (CH) | 2024-12-18 | — | — | EP | claimed |
| US-11886045-B2 | Method for making photochromic contact lenses | ALCON INC. (CH) | 2024-01-30 | — | — | US | claimed |
| WO-2023209570-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-02 | — | — | WO | claimed |
| US-20230339149-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-10-26 | — | — | US | claimed |
| EP-4240578-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | Alcon Inc. (CH) | 2023-09-13 | — | — | EP | claimed |
| WO-2022097048-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-12 | — | — | WO | claimed |
| US-20220137433-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-05 | — | — | US | claimed |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | disclosed |
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | disclosed |
| EP-4514595-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | disclosed |
| EP-4240578-B1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC (CH) | 2024-12-18 | — | — | EP | disclosed |
| US-11886045-B2 | Method for making photochromic contact lenses | ALCON INC. (CH) | 2024-01-30 | — | — | US | disclosed |
| WO-2023209570-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-02 | — | — | WO | disclosed |
| US-20230339149-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-10-26 | — | — | US | disclosed |
| EP-4240578-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | Alcon Inc. (CH) | 2023-09-13 | — | — | EP | disclosed |
| CN-114524781-A | Lipid composition | 阿布特斯生物制药公司 | 2022-05-24 | — | — | CN | disclosed |
| WO-2022097048-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-12 | — | — | WO | disclosed |
| US-20220137433-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | INF2, CRYZ, CRYAA | HTR1A 4807/4885KDM1A 1815/4885MAOB 4396/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | HTR1A 4758/4885KDM1A 3012/4885MAOB 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.